Evaluation of the EMulate Therapeutics Voyager’s ultra-low radiofrequency energy in murine model of glioblastoma
Abstract Background Glioblastoma (GBM) presents as an aggressive brain cancer, notorious for its recurrence and resistance to conventional treatments. This study aimed to assess the efficacy of the EMulate Therapeutics Voyager®, a non-invasive, non-thermal, non-ionizing, battery-operated, portable e...
Main Authors: | Rajesh Mukthavaram, Pengfei Jiang, Sandra Pastorino, Natsuko Nomura, Feng Lin, Santosh Kesari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | Bioelectronic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42234-024-00143-8 |
Similar Items
-
Natural dietary compound naringin inhibits glioblastoma cancer neoangiogenesis
by: Sonia Aroui, et al.
Published: (2020-06-01) -
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma
by: Garni Barkhoudarian, et al.
Published: (2023-09-01) -
Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis
by: Takayuki Morimoto, et al.
Published: (2024-02-01) -
Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma
by: Mona M. Al-Gizawiy, et al.
Published: (2024-01-01) -
Does Unidirectional Block Exist after a Radiofrequency Line Creation? Insights from Ultra-High-Density Mapping (The UNIBLOCK Study)
by: Sok-Sithikun Bun, et al.
Published: (2021-06-01)